Rising Number of Cancer Cases Making India Potential Market for Anti-Cancer Drugs, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Oncology Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series.
Mumbai, India, April 21, 2012 --(PR.com)-- Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its Oncology Pharmaceuticals Market in India 2012 report. The market is expected to show steady growth owing to the increasing cancer cases, especially lung and breast cancer.
The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export figures of cancer drugs in India in terms of value. Regional break-up of the imports and exports have been included.
An analysis of the drivers explains the factors for growth of the industry including increasing cancer cases, changes in the treatment scenario, development of alternative cancer therapies, increasing FDI and increase in the number of cancer health insurances. The key challenges include increased competition, drug patent problems and drug portfolio management problems.
The government initiatives section highlights the PPP R&D projects started in the country. It also analyses the various initiatives undertaken to reduce prices of cancer drugs, the various cancer control programmes implemented and the changes in the custom duty structure.
A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals.
The competition section gives overview of pharmaceutical companies in the country operating in the cardiovascular pharmaceutical industry. The report highlights features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. It also incorporates the recent developments in the Oncology Pharmaceutical industry.
For more details on the content of each report and ordering information please contact:
Tel: +91 33 4064 6214
Email: sales@netscribes.com
The report begins with the market overview section which provides an insight into the global market, highlighting the market size and growth. It then moves onto the Indian market, with a focus on market size and growth. It also provides import and export figures of cancer drugs in India in terms of value. Regional break-up of the imports and exports have been included.
An analysis of the drivers explains the factors for growth of the industry including increasing cancer cases, changes in the treatment scenario, development of alternative cancer therapies, increasing FDI and increase in the number of cancer health insurances. The key challenges include increased competition, drug patent problems and drug portfolio management problems.
The government initiatives section highlights the PPP R&D projects started in the country. It also analyses the various initiatives undertaken to reduce prices of cancer drugs, the various cancer control programmes implemented and the changes in the custom duty structure.
A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals.
The competition section gives overview of pharmaceutical companies in the country operating in the cardiovascular pharmaceutical industry. The report highlights features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. It also incorporates the recent developments in the Oncology Pharmaceutical industry.
For more details on the content of each report and ordering information please contact:
Tel: +91 33 4064 6214
Email: sales@netscribes.com
Contact
Netscribes India Pvt. Ltd.
Gaurav Kumar
+91 33 4064 6214
www.netscribes.com
Gaurav Kumar
+91 33 4064 6214
www.netscribes.com
Contact
Categories